Sustainability | March 06, 2025
J. B. Chemicals & Pharmaceuticals announces DJSI score of 77
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
The acquisition will strengthen the overall company’s position as leading global CRO services partner
The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Dozee plans to further tap over 2,000 hospitals in more than 100 districts
The company sees the business reaching $100mn
Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Subscribe To Our Newsletter & Stay Updated
